Showing Results for: “diabetes”

Findings Highlight the Impact of Insurance Barriers on Managed Diabetes Care for Diverse Populations Living with Type 1 Diabetes Results from a new study show the impact and importance of continuous glucose monitoring (CGM) that young individuals with diabetes face today. The findings were presented as a Late-Breaking Poster at the 84 th Scientific Sessions of the American Diabetes Association® (ADA) in Orlando, FL. Health disparities is a growing concern that significantly impacts diabetes. In nearly all states, those who identify as Black and Native American are more likely than those who

The American Diabetes Association® applauds the Utah governor and legislature for passing HB 207 Recently, Utah Governor Gary Herbert signed into law American Diabetes Association-supported legislation capping monthly copayments for insulin at $30 for a 30-day supply. House Bill 207 (HB 207) also includes an emergency refill provision that will allow people without an up-to-date prescription to get insulin immediately rather than waiting until they are able to get a refill authorized by a physician, as well as a provision directing the Utah Department of Insurance to issue a report that

In a submission today to the Senate Finance Committee’s hearing, Bolstering Chronic Care through Medicare Physician Payment, the American Diabetes Association® (ADA) is urging policymakers to boost Medicare payments to physicians and primary care delivery teams to improve care for people with diabetes. A National Policy Roundtable on Diabetes and Primary Care hosted earlier this year by the ADA, and joined by major physician and patient advocacy organizations, made clear that increased reimbursement for all members of a primary care team can both alleviate the health care workforce shortage

James Wrobel, DPM, MS, has been selected to receive the American Diabetes Association’s® (ADA’s) 2019 Roger Pecoraro Award. This award recognizes a researcher who has made significant scientific contributions and demonstrates an untiring commitment to improving the understanding of the detection, treatment, and prevention of diabetic foot complications. Dr. Wrobel will be recognized with this honor during the ADA’s 79th Scientific Sessions, June 7-11, 2019, at the Moscone Convention Center in San Francisco. He will deliver the Roger Pecoraro Award Lecture, “ Artificial Intelligence for

The American Diabetes Association® applauds New Hampshire’s governor and legislature for passing a cap on insulin co-pays Today, New Hampshire House Bill 1280 was signed into law by Governor Chris Sununu. A provision in the law limits cost sharing for insulin to $30 per 30-day supply for those with state-regulated commercial health insurance, a measure supported by the American Diabetes Association (ADA). The new law will take effect on September 14, 2020. Stephen Habbe, Director for State Government Affairs for the ADA, issued the following statement: “One of the most urgent issues faced by

Bipartisan King-Murkowski bill allocates testing resources for communities most at-risk The American Diabetes Association® (ADA), the nation’s leading organization for all people living with diabetes, announced its strong support for the COVID-19 Testing, Reaching, And Contacting Everyone (TRACE) Act in a letter to Senators Angus King (I-ME) and Lisa Murkowski (R-AK), who introduced the bill. The ADA also called on all Members of Congress to support this important legislation. The bill ensures that local organizations get the resources they need to mobilize testing and contact tracing efforts

“The American Diabetes Association ® (ADA) is the leading voice advocating for insulin affordability and is working to ensure that all people with diabetes have access to the care they need. We applaud Eli Lilly for taking the important step to limit cost-sharing for its insulin, and we encourage other insulin manufacturers to do the same. While we have been able to help achieve significant progress on the issue of insulin affordability, including Medicare’s new out-of-pocket cost cap on insulin, state copay caps, and patient assistance developments from insulin manufacturers, we know that our

In response to the U.S. Department of Education’s recent announcement of its intention to move oversight of civil rights to the U.S. Department of Justice and special education services to the U.S. Department of Health and Human Services, the American Diabetes Association ® (ADA) issued the following statement. Children with disabilities, including diabetes, have legal protections under federal laws such as Section 504 of the Rehabilitation Act of 1973, enforced by the Office for Civil Rights (OCR), and the Individuals with Disabilities Education Act, enforced by the Office of Special

Today, Maryland Governor Wes Moore signed Senate Bill 646/House Bill 970 to prohibit state-regulated plans from imposing step therapy, or fail-first protocol, for insulin used to treat type 1, type 2, or gestational diabetes. Many patients with diabetes rely on insulin to manage their condition and prevent life-threatening complications. However, some insurance companies enforce "step therapy" or "fail-first" protocols requiring patients to try one or more less expensive or insurer-preferred insulin options before accessing the prescribed insulin their clinician considers most appropriate

According to a new nationwide survey, the 34 million Americans living with diabetes face unique, acute and intensified challenges to their health as a result of the COVID-19 pandemic – challenges that may increase their COVID risk for complications. The study, released today by the American Diabetes Association® in partnership with Thrivable and the Diabetes Daily community, shows that the financial and economic toll of the pandemic has left scores of Americans with diabetes without access to the drugs, devices, insurance, and food that they need to properly manage their diabetes or even